Patterns of antidepressant treatment changes among adults with major depressive disorder in Northwest Ethiopia: a hospital-based cross-sectional study
Therapeutic Advances in Psychopharmacology · 2026-07 · 16
DOI: 10.1177/20451253261463711 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 15.07.2026. Verfasst von Tilaye Arega Moges und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabo…. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Major depressive disorder (MDD) is a prominent cause of worldwide disability, severely affecting quality of life in Ethiopia. Despite a significant prevalence of treatment-resistant depression, challenges in treatment adherence, and a high prevalence of adverse drug reactions, the studies in Ethiopia have limited data on antidepressant treatment changes.
Objectives
This research aims to identify patterns of antidepressant treatment changes, the reasons for treatment changes, and associated factors among patients with MDD in Ethiopia.
Design
A hospital-based cross-sectional study.
Methods
The present study was conducted at Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia, from June 01, 2025, to August 30, 2025. The data was entered, cleaned, and analyzed by using SPSS Version 27. The antidepressant side-effect checklist was used to classify adverse effects as mild, moderate, or severe. The Naranjo adverse drug reactions (ADRs) probability scale assessed antidepressant-related adverse drug reactions; non-adherence was evaluated using a self-reported tablet count tool. A multivariable logistic regression model was utilized to identify factors associated with antidepressant treatment changes. The significance level was set at a p -value of 0.05, with a 95% confidence interval (CI).
Results
Out of 220 respondents, 127 (57.7%) did not respond to their antidepressants, which impacted their ability to carry out daily responsibilities. Approximately one-third of participants (80, or 36.4%) had switched medications. More than half of the patients with MDD (114, or 51.82%) experienced ADRs related to antidepressants. The prevalence of non-adherence to medication was 54.6%; 95% CI: 48.6, 60.9. Antidepressant treatment change was significantly associated with having a history of relapse (AOR = 2.52, 95% CI: 1.28, 5.42) and a history of hospital admission (AOR = 2.35, 95% CI: 1.25, 7.59).
Conclusion
The management of MDD in Ethiopia faces challenges such as high non-adherence rates, significant ADRs, and limited access to alternative treatments. About 36.4% of patients underwent antidepressant treatment changes. A history of relapse and admission history were associated with antidepressant treatment changes. Future research should investigate longitudinal research to understand non-response and its impact on patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, P.O. Box 272, Ethiopia.
- Department of Pharmacy, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.
- Department of Pharmacology and Toxicology, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
- Department of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
- Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
ORCID-Profile: Tilaye Arega Moges, Fasil Bayafers Tamene, Woretaw Sisay Zewdu, Tigabu Eskeziya Zerihun, Abel Temeche Kassaw, Samuel Agegnew Wondm, Abaynesh Fentahun Bekalu, Samuel Berihun Dagnew
Zitieren
APA
Moges, T. A., Tamene, F. B., Zewdu, W. S., Tarekegn, G. Y., Dejen, A., Zerihun, T. E., Kassaw, A. T., Mussie, D. A., Wondm, S. A., Bekalu, A. F., & Dagnew, S. B. (2026). Patterns of antidepressant treatment changes among adults with major depressive disorder in Northwest Ethiopia: a hospital-based cross-sectional study. Therapeutic Advances in Psychopharmacology, 16. https://doi.org/10.1177/20451253261463711
Vancouver
Moges TA, Tamene FB, Zewdu WS, Tarekegn GY, Dejen A, Zerihun TE, et al. Patterns of antidepressant treatment changes among adults with major depressive disorder in Northwest Ethiopia: a hospital-based cross-sectional study. Therapeutic Advances in Psychopharmacology. 2026;16. doi:10.1177/20451253261463711
BibTeX
@article{Moges2026,
author = {Moges, Tilaye Arega and Tamene, Fasil Bayafers and Zewdu, Woretaw Sisay and Tarekegn, Getachew Yitayew and Dejen, Asanti and Zerihun, Tigabu Eskeziya and Kassaw, Abel Temeche and Mussie, Desalegn Addis and Wondm, Samuel Agegnew and Bekalu, Abaynesh Fentahun and Dagnew, Samuel Berihun},
title = {Patterns of antidepressant treatment changes among adults with major depressive disorder in Northwest Ethiopia: a hospital-based cross-sectional study},
journal = {Therapeutic Advances in Psychopharmacology},
year = {2026},
volume = {16},
doi = {10.1177/20451253261463711}
}
EUVIMED